FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)

FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)

http://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-removes-boxed-warning-abou...

Source: FDA Center for Drug Evaluation and Research - What's New - September 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Canagliflozin | Diabetes | Drugs & Pharmacology | Endocrinology | Invokana | Warnings